Tirzepatide 20mg
Dual GIP & GLP-1 Receptor Agonist
$75.00$55.00
Grade: Research Grade / Analytical Standard
Purity: ≥99% (HPLC Verified)
Format: Lyophilized (Freeze-Dried) Powder
Unit Size: 20 mg
Product Overview
Tirzepatide 20mg is a high-potency, synthetic dual-acting peptide developed for advanced scientific research into incretin co-agonism and metabolic signaling networks. As a first-in-class dual GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonist, Tirzepatide engages two primary incretin pathways simultaneously.
This 20mg high-yield format provides researchers with an optimal volume for extended experimental series, dose-response kinetics, and robust comparative assays against single-receptor mimetics.
Key Research Features & Highlights
Dual-Agonist Pathway Mechanics: Uniquely activates both GIP and GLP-1 receptors to facilitate comprehensive study of synergistic metabolic signaling.
High-Yield 20mg Capacity: Ideal for multi-run laboratory trials, high-throughput assays, and extended research protocols without requiring multiple smaller vials.
Engineered Stability: Features an amino acid backbone modified with a C20 fatty diacid diacyl chain, providing extended stability and half-life for prolonged assay observation.
Ultra-High Purity (≥99%): Standardized and batch-tested using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) for maximum purity and experimental repeatability.
Primary Applications in Laboratory Research
Synergistic Incretin Signaling: Analyzing the combined biological impact of dual GIP/GLP-1 activation versus single GLP-1 pathway stimulation.
Glycemic & Energy Metabolism: Researching glucose-dependent insulin secretion, glucagon regulation, and cellular lipid utilization.
Nutrient Sensing & Central Signaling: Modeling hypothalamic pathways that control satiety, appetite suppression, and gastric emptying dynamics.
Comparative Agonist Profiling: Benchmarking dual-agonist dynamics against mono-agonists (e.g., Semaglutide) and tri-agonists (e.g., Retatrutide).
Product Specifications
Attribute | Specification |
Active Compound | Tirzepatide (LY3298176) |
Net Quantity | 20 mg |
Form | Lyophilized White Powder |
CAS Number | 2023788-19-2 |
Molecular Mass | ~4813.45 g/mol |
Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
Purity Standard | ≥99% (HPLC verified) |
Solubility | Soluble in Bacteriostatic Water or Sterile Deionized Water |
Storage & Handling Protocols
Unreconstituted (Lyophilized): Store at or below -20°C in a cool, dark environment away from humidity and direct UV light.
Reconstituted Solution: Maintain at 2°C – 8°C after adding sterile solvent, and utilize within 30 days to retain peak peptide performance. Avoid repeated freeze-thaw cycles.
Mandatory Research & Legal Disclaimer
FOR LABORATORY RESEARCH USE ONLY. This compound is distributed strictly for scientific, analytical, and educational laboratory applications. It is not intended for human or animal consumption, medical therapy, diagnostic procedures, or commercial formulation.